High-level ciprofloxacin resistance in Salmonella entericaserotype Typhi in India

被引：45

作者：

Renuka, K ^{[1
]}

Sood, S ^{[1
]}

Das, BK ^{[1
]}

Kapil, A ^{[1
]}

机构：

[1] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India

来源：

JOURNAL OF MEDICAL MICROBIOLOGY | 2005年 / 54卷 / 10期

关键词：

D O I：

10.1099/jmm.0.45966-0

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：999 / 1000

页数：2

共 14 条

[1] Is it time to change fluoroquinolone breakpoints for Salmonella spp.? [J].

Aarestrup, FM ;

Wiuff, C ;

Molbak, K ;

Threlfall, EJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) :827-829

[2]

[Anonymous], PERF STAND ANT DISC

[3] Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India [J].

Brown, JC ;

Shanahan, PMA ;

Jesudason, MV ;

Thomson, CJ ;

Amyes, SGB .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (05) :891-900

[4]

EYKYN SJ, 1987, LANCET, V2, P1407

[5] Isolated high-level ciprofloxacin resistance in Salmonella enterica subsp enterica serotype Paratyphi A [J].

Harish, BN ;

Madhulika, U ;

Parija, SC .

JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 53 (08) :819-819

[6] DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A [J].

Hirose, K ;

Hashimoto, A ;

Tamura, K ;

Kawamura, Y ;

Ezaki, T ;

Sagara, H ;

Watanabe, H .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (10) :3249-3252

[7]

Jesudason MV, 1996, INDIAN J MED RES, V103, P247

[8]

Kapil A, 2002, INDIAN J MED RES, V115, P49

[9] Ciprofloxacin in typhoid fever [J].

Kapil, A ;

Sood, S ;

Dash, NR ;

Das, BK ;

Seth, P .

LANCET, 1999, 354 (9173) :164-164

[10]

Launay Odile, 1997, Clin Microbiol Infect, V3, P541, DOI 10.1111/j.1469-0691.1997.tb00304.x

← 1 2 →